等待开盘 11-18 09:30:00 美东时间
-0.384
-1.15%
数据显示,NDIV前十大重仓股合计占基金资产的54.0805%。 其中,第一大重仓股为欧林,持仓占比5.9394%;第二大重仓股为SLVM,占比5.9157%...
11-14 07:16
数据显示,NDIV前十大重仓股合计占基金资产的53.7305%。 其中,第一大重仓股为欧林,持仓占比6.1490%;第二大重仓股为美国美盛,占比5.8423%...
11-07 07:12
Eton Pharmaceuticals has launched ET-900, a new program evaluating mecasermin (IGF-1) for treating infantile and epileptic spasms. The company licensed patent rights from Baylor College of Medicine for IGF-1 use in spasms. Preclinical research showed IGF-1 therapy reduced spasms in animals. An IND application for a Phase 2 study in children with refractory epileptic spasms has been submitted to the FDA, with dosing planned for Q1 2027. Eton retai...
11-02 11:50
Eton Pharmaceuticals, Inc. will report third quarter 2026 financial results on November 5, 2026. Management will host a conference call and live audio webcast at 4:30 p.m. ET, with links provided for participants and webcast access. Investors can submit questions via email to investorrelations@etonpharma.com. An archived webcast will be available on Eton’s website for 30 days. Eton focuses on developing treatments for rare diseases, with twelve a...
10-29 10:50
TotalEnergies SE (NYSE:TTE) will acquire a 25% working interest in 26 Chevron Corporation-operated exploration leases offshore the U.S., the companies disclosed Wednesday. In a reciprocal transaction, Chevron (NYSE:CVX) will acquire a 75% operated interest in two adjacent leases from TotalEnergies. ...
10-28 23:07
Eton Pharmaceuticals and Aquestive Therapeutics have entered an exclusive agreement to commercialize LIBERVANT, a buccal film for seizure clusters in epilepsy patients. LIBERVANT, designated as an Orphan Drug, offers a portable alternative to nasal and rectal treatments, with strong patient preference (71%) and a U.S. market potential exceeding $450 million annually. Anticipated launch in April 2027, pending FDA approval, expands Eton's rare dise...
10-14 10:50
Eton Pharmaceuticals ( ($ETON) ) has issued an announcement. On July 29, 2026, ...
07-29 19:33
Addex Therapeutics (NASDAQ:ADXN) held its fourth-quarter earnings conference ca...
04-30 22:52